Heron Therapeutics Inc (NASDAQ:HRTX)

13.30
Delayed Data
As of Apr 17
 -0.93 / -6.54%
Today’s Change
6.51
Today|||52-Week Range
16.49
+32.21%
Year-to-Date
No recent news for Heron Therapeutics Inc.

Today’s Trading

Previous close14.23
Today’s open14.10
Day’s range12.94 - 14.23
Volume364,012
Average volume (3 months)228,308
Market cap$420.2M
Dividend yield--
Data as of 3:59pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)+16.08%
Earnings growth (this year)-4.11%
Earnings growth (next 5 years)+64.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book6.60

Competitors

 Today’s
change
Today’s
% change
VNDAVanda Pharmaceutical...-0.19-1.88%
IDRAIdera Pharmaceutical...-0.14-3.90%
PRTKParatek Pharmaceutic...-1.18-3.99%
AMPEAmpio Pharmaceutical...-0.10-1.25%
Data as of 4:03pm ET, 04/17/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.68
Annual revenue (last year)$0.00
Annual profit (last year)-$76.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Barry D. Quart
President &
Director
Robert H. Rosen
Corporate headquarters
Redwood City, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers